2h
Asianet Newsable on MSNNew antibody reduces tumor growth in tough-to-treat breast and ovarian cancers: StudyImmunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...
A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which ...
Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...
A study has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of ...
Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...
A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and slows tumour growth in ...
Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...
3d
News Medical on MSNGut microbiota impacts pneumococcal vaccine response in immunodeficient individualsGut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia.
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results